Literature DB >> 16563235

Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells.

K T Moe1, S Aulia, F Jiang, Y L Chua, T H Koh, M C Wong, G J Dusting.   

Abstract

NADPH oxidases are important sources of vascular superoxide, which has been linked to the pathogenesis of atherosclerosis. Previously we demonstrated that the Nox4 subunit of NADPH oxidase is a critical catalytic component for superoxide production in quiescent vascular smooth muscle cells. In this study we sought to determine the role of Nox4 in superoxide production in human aortic smooth muscle cells (AoSMC) and embryonic kidney (HEK293) cells under proinflammatory conditions. Incubation with tumor necrosis factor-alpha (TNF-alpha, 10 ng/ml) for 12 h increased superoxide production in both cell types, whereas angiotensin II, platelet-derived growth factor or interleukin-1beta had little effects. Superoxide production was completely abolished by the NADPH oxidase inhibitors diphenyline iodonium and apocynin, but not by inhibitors of xanthine oxidase, nitric oxide synthase or mitochondrial electron transport. TNF-alpha upregulated the expression of Nox4 in AoSMC at both message and protein levels, while Nox1 and Nox2 were unchanged. In contrast, upregulation of Nox2 appeared to mediate the enhanced superoxide production by TNF-alpha in HEK293 cells. We suggest that Nox4 may be involved in increased superoxide generation in vascular smooth muscle cells under proinflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563235      PMCID: PMC3933115          DOI: 10.1111/j.1582-4934.2006.tb00304.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  42 in total

1.  Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases.

Authors:  Kendra D Martyn; Linda M Frederick; Katharina von Loehneysen; Mary C Dinauer; Ulla G Knaus
Journal:  Cell Signal       Date:  2005-05-31       Impact factor: 4.315

2.  Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure.

Authors:  P Ferdinandy; H Danial; I Ambrus; R A Rothery; R Schulz
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

3.  Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle.

Authors:  G W De Keulenaer; R W Alexander; M Ushio-Fukai; N Ishizaka; K K Griendling
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

4.  Cell transformation by the superoxide-generating oxidase Mox1.

Authors:  Y A Suh; R S Arnold; B Lassegue; J Shi; X Xu; D Sorescu; A B Chung; K K Griendling; J D Lambeth
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

5.  Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.

Authors:  B Lassègue; D Sorescu; K Szöcs; Q Yin; M Akers; Y Zhang; S L Grant; J D Lambeth; K K Griendling
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

6.  Identification of renox, an NAD(P)H oxidase in kidney.

Authors:  M Geiszt; J B Kopp; P Várnai; T L Leto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

7.  Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator.

Authors:  Jingxiong Wang; Huizhen Wang; Yiqiang Zhang; Huanhuan Gao; Stanley Nattel; Zhiguo Wang
Journal:  J Biol Chem       Date:  2004-02-17       Impact factor: 5.157

8.  Receptor binding assay for paralytic shellfish poisoning toxins: optimization and interlaboratory comparison.

Authors:  Shryamalie R Ruberu; Yun-Gang Liu; Carolyn T Wong; S Kusum Perera; Gregg W Langlois; Gregory J Doucette; Christine L Powell
Journal:  J AOAC Int       Date:  2003 Jul-Aug       Impact factor: 1.913

9.  Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery.

Authors:  Saima Muzaffar; Nilima Shukla; Clinton Lobo; Gianni D Angelini; Jamie Y Jeremy
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

10.  TNF-alpha induces phosphorylation of p47(phox) in human neutrophils: partial phosphorylation of p47phox is a common event of priming of human neutrophils by TNF-alpha and granulocyte-macrophage colony-stimulating factor.

Authors:  Cédric Dewas; Pham My-Chan Dang; Marie-Anne Gougerot-Pocidalo; Jamel El-Benna
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

View more
  37 in total

Review 1.  Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.

Authors:  Jennifer Rivera; Christopher G Sobey; Anna K Walduck; Grant R Drummond
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 2.  Jack of all trades: pleiotropy and the application of chemically modified tetracycline-3 in sepsis and the acute respiratory distress syndrome (ARDS).

Authors:  Shreyas K Roy; Daniel Kendrick; Benjamin D Sadowitz; Louis Gatto; Kathleen Snyder; Joshua M Satalin; Lorne M Golub; Gary Nieman
Journal:  Pharmacol Res       Date:  2011-06-21       Impact factor: 7.658

Review 3.  Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.

Authors:  Grant R Drummond; Stavros Selemidis; Kathy K Griendling; Christopher G Sobey
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 4.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

Review 5.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?

Authors:  Yves Gorin; Karen Block
Journal:  Free Radic Biol Med       Date:  2013-03-23       Impact factor: 7.376

6.  The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1.

Authors:  Isabel Diebold; Andreas Petry; John Hess; Agnes Görlach
Journal:  Mol Biol Cell       Date:  2010-04-28       Impact factor: 4.138

7.  Tumor necrosis factor-α-induced nuclear factor-kappaB activation in human cardiomyocytes is mediated by NADPH oxidase.

Authors:  Kyaw Thu Moe; Katwadi Khairunnisa; Nwe Oo Yin; Jaye Chin-Dusting; Philip Wong; Meng Cheong Wong
Journal:  J Physiol Biochem       Date:  2014-07-25       Impact factor: 4.158

8.  Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy.

Authors:  V V Barygina; M Becatti; G Soldi; F Prignano; T Lotti; P Nassi; D Wright; N Taddei; C Fiorillo
Journal:  Redox Rep       Date:  2013-04-19       Impact factor: 4.412

Review 9.  Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases.

Authors:  Roman Ginnan; Benjamin J Guikema; Katharine E Halligan; Harold A Singer; David Jourd'heuil
Journal:  Free Radic Biol Med       Date:  2008-01-22       Impact factor: 7.376

10.  Inflammatory cytokines suppress arylamine N-acetyltransferase 1 in cholangiocarcinoma cells.

Authors:  Benjaporn Buranrat; Auemduan Prawan; Banchob Sripa; Veerapol Kukongviriyapan
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.